https://apnews.com/f46f42fc81fb17401b0c5f0902b06367

BERLIN -- German pharmaceutical company CureVac says it is receiving a further 252 million euros ($298 million) to develop a coronavirus vaccine.

The company says its request for additional funding has been approved by Germany’s Ministry for Education and Research, provided certain milestones are reached.